Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

The 3 Drivers Behind The Big Pharma Rally
Seeking Alpha
Friday, April 26, 2013 - 10:36am
tags:
Eli Lilly, Merck, Pfizer, Questcor, Bristol-Myers Squibb
Pfizer’s Arthritis Drug Rejected by European Regulators
Bloomberg
Friday, April 26, 2013 - 10:35am
tags:
Pfizer, Europe, rheumatoid arthritis, Xeljanz
Doctors blast ethics of $100,000 cancer drugs
CNN Money
Friday, April 26, 2013 - 10:34am
tags:
physicians, drug pricing, CML, Gleevec, Novartis
Eli Lilly's Promising Stage III Pipeline Could Jumpstart Its Dividend
Seeking Alpha
Friday, April 26, 2013 - 10:32am
tags:
Eli Lilly, dividends
Bayer Profit Barely Rises as Plastics Offset New Drugs
Bloomberg
Thursday, April 25, 2013 - 11:43am
tags:
earnings, Bayer
Busy Novartis announces layoffs, taps new CFO, and slashes chairman's pay
Fierce Pharma
Thursday, April 25, 2013 - 11:28am
tags:
layoffs, earnings, executive pay, Novartis
[video]The Key Earnings Details of the Medical Device Industry
Motley Fool
Thursday, April 25, 2013 - 11:27am
tags:
earnings, devices, St. Jude Medical, JNJ, Abbott Laboratories, Boston Scientific
Immunogen Earnings Preview: Get Ahead of the Analysts
Wall St. Cheat Sheet
Thursday, April 25, 2013 - 11:24am
tags:
earnings, Immunogen
Psoriasis Med Similiar To Biogen MS Pill Is Linked To Brain Disease
Pharmalot
Thursday, April 25, 2013 - 10:56am
tags:
multiple sclerosis, Biogen Idec, psoriasis, PML, Tecfidera, Fumaderm
AstraZeneca gets U.S. subpoena over UK drug factory
Reuters
Thursday, April 25, 2013 - 10:54am
tags:
AstraZeneca
Celgene profit beats estimates as demand for cancer drugs rise
Reuters
Thursday, April 25, 2013 - 10:48am
tags:
earnings, Celgene
Alexion Reports First Quarter 2013 Results
Yahoo
Thursday, April 25, 2013 - 10:45am
tags:
earnings, Alexion
Valeant completes tender offer for Obagi Medical
Yahoo/Fly on the Wall
Thursday, April 25, 2013 - 10:45am
tags:
Valeant Pharmaceuticals, Obagi Medical Products, M&A
Biogen Idec 1Q income rises on lower tax rate
Yahoo/AP
Thursday, April 25, 2013 - 10:44am
tags:
earnings, Biogen Idec
Eli Lilly Sues J&J for Patents Rights in Alzheimer Drug Race
Bloomberg
Thursday, April 25, 2013 - 10:43am
tags:
JNJ, patents, Eli Lilly, Alzheimer's disease, solanezumab
In Moribund Cholesterol Field, A New Drug Emerges
Forbes
Thursday, April 25, 2013 - 9:27am
tags:
ETC-1002, Pfizer, Esperion, Merck, Amgen, Sanofi, AstraZeneca
Bristol profit drops sharply, but meets Wall Street forecast
Reuters
Thursday, April 25, 2013 - 9:26am
tags:
earnings, Bristol-Myers Squibb
Why Aveo's Kidney Cancer Drug Will Be Turned Down By Next Week's FDA Panel
TheStreet.com
Thursday, April 25, 2013 - 9:25am
tags:
Aveo Pharmaceuticals, kidney cancer, FDA, advisory panels, tivozanib
Sarepta Therapeutics: Irrational Exuberance
Seeking Alpha
Thursday, April 25, 2013 - 9:24am
tags:
Sarepta, GSK, eteplirsen, Duchenne Muscular Dystrophy
How Will AbbVie's Earnings Fare?
Motley Fool
Thursday, April 25, 2013 - 9:22am
tags:
AbbVie, earnings

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.